References in periodicals archive ?
FVCG has invested in Actinobac to advance its work for the treatment of hematological malignancies (leukemias & lymphomas), autoimmune diseases (rheumatoid arthritis, multiple sclerosis, Crohn's disease, type 1 diabetes, lupus, psoriasis) as well as HIV infection.
Two abdominal measurements with a high SNR measured at a gestational age of 22 weeks and 24 weeks, respectively, were selected from the dataset described in  for extraction of a fVCG. Figure 3 shows the three orthogonal projections of a fVCG obtained from these recordings, as well as a plot of the 2nd electrode ([L.sub.2]) of the abdominal recording, both measured and simulated.
FVCG has made an initial investment of $175,000 in Celvive, which can go up to $500,000 pending completion of certain milestones.
Equation FVCG shows the total accumulated gain or total tax-deferred return component of total return for a lump sum investment of PV dollars.
Acronyms browser ?
Full browser ?